Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
4
Lennar Corp
LEN
5
Adobe
ADBE
US Stock MarketDetailed Quotes
QNRX Quoin Pharmaceuticals
- 6.411
- -0.169-2.57%
Trading Apr 30 14:07 ET
3.77MMarket Cap-0.10P/E (TTM)
6.950High6.280Low30.66KVolume6.780Open6.580Pre Close202.57KTurnover5.61%Turnover RatioLossP/E (Static)588.17KShares54.95052wk High0.41P/B3.50MFloat Cap5.01052wk Low--Dividend TTM546.54KShs Float1417500.000Historical High--Div YieldTTM10.18%Amplitude5.010Historical Low6.606Avg Price1Lot Size
Quoin Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 1.60%9.53M | 8.45%2.41M | 18.95%2.53M | -5.44%2.14M | -11.43%2.46M | 1.30%9.38M | 6.32%2.22M | -8.69%2.13M | -15.30%2.26M | 27.55%2.78M |
| Selling and administrative expenses | -2.38%5.93M | -3.64%1.33M | -0.64%1.36M | -1.05%1.62M | -4.06%1.62M | -7.81%6.07M | -5.95%1.39M | -13.63%1.37M | -15.79%1.63M | 6.00%1.68M |
| -General and administrative expense | -2.38%5.93M | -3.64%1.33M | -0.64%1.36M | -1.05%1.62M | -4.06%1.62M | -7.81%6.07M | -5.95%1.39M | -13.63%1.37M | -15.79%1.63M | 6.00%1.68M |
| Research and development costs | 8.91%3.6M | 28.57%1.07M | 54.24%1.17M | -16.92%519.35K | -22.80%842.83K | 23.76%3.31M | 35.77%832.39K | 1.78%758.76K | -13.98%625.1K | 85.81%1.09M |
| Operating profit | -1.60%-9.53M | -8.45%-2.41M | -18.95%-2.53M | 5.44%-2.14M | 11.43%-2.46M | -1.30%-9.38M | -6.32%-2.22M | 8.69%-2.13M | 15.30%-2.26M | -27.55%-2.78M |
| Net non-operating interest income expense | -19.60%558.49K | -31.04%109.33K | -25.47%146.39K | -11.90%165.26K | -9.56%137.51K | 212.34%694.61K | 96.68%158.55K | 128.10%196.43K | 187.59K | 152.05K |
| Non-operating interest income | -19.60%558.49K | -31.04%109.33K | -25.47%146.39K | -11.90%165.26K | -9.56%137.51K | 625.48%694.61K | 96.68%158.55K | 1,198.08%196.43K | --187.59K | --152.05K |
| Other net income (expense) | 379.61%7.5K | -268.14%-15.54K | 1,397.36%31.73K | 93.68%-2.18K | -131.86%-6.51K | -100.54%-2.68K | 112.00%9.24K | 169.41%2.12K | -34.47K | -95.86%20.43K |
| Gain on sale of security | 379.61%7.5K | -268.14%-15.54K | 1,397.36%31.73K | 93.68%-2.18K | -131.86%-6.51K | -305.28%-2.68K | 112.68%9.24K | 169.41%2.12K | ---34.47K | -73.55%20.43K |
| Income before tax | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Income tax | ||||||||||
| Net income | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Net income continuous Operations | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 8.05%-8.69M | -2.44%-2.05M | 37.75%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Basic earnings per share | 80.19%-66.85 | 83.14%-12.25 | 75.90%-16.45 | 81.69%-13.65 | 72.86%-38.85 | 79.41%-337.4 | 58.09%-72.6745 | 82.71%-68.25 | 94.53%-74.55 | 86.42%-143.15 |
| Diluted earnings per share | 80.19%-66.85 | 83.17%-12.25 | 75.90%-16.45 | 81.69%-13.65 | 72.86%-38.85 | 79.41%-337.4 | 58.02%-72.8 | 82.71%-68.25 | 94.53%-74.55 | 86.42%-143.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025